Cargando…
NF‐κB/NKILA signaling modulates the anti‐cancerous effects of EZH2 inhibition
A wealth of evidence supports the broad therapeutic potential of NF‐κB and EZH2 inhibitors as adjuvants for breast cancer treatment. We contribute to this knowledge by elucidating, for the first time, unique regulatory crosstalk between EZH2, NF‐κB and the NF‐κB interacting long non‐coding RNA (NKIL...
Autores principales: | Duan, Suzann, Chan, Westin K., Oman, Andrew, Basile, Dominic P., Alvira, Cristina M., Buxton, Iain L.O., Iosef, Cristiana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714229/ https://www.ncbi.nlm.nih.gov/pubmed/31282094 http://dx.doi.org/10.1111/jcmm.14500 |
Ejemplares similares
-
Distinct roles for IκB kinases alpha and beta in regulating pulmonary endothelial angiogenic function during late lung development
por: Iosef, Cristiana, et al.
Publicado: (2018) -
NKILA inhibits NF-κB signaling and suppresses tumor metastasis
por: Ke, Shun, et al.
Publicado: (2018) -
NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
por: Zhang, Wei, et al.
Publicado: (2019) -
Expression of Concern: NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
Publicado: (2022) -
lncRNA‐NKILA/NF‐κB feedback loop modulates laryngeal cancer cell proliferation, invasion, and radioresistance
por: Yang, Tao, et al.
Publicado: (2018)